Evaluating determinants of receipt of molecular imaging in biochemical recurrent prostate cancer
Sign Up to like & getrecommendations! Published in 2020 at "Cancer Medicine"
DOI: 10.1002/cam4.3555
Abstract: Molecular imaging with novel radiotracers is changing the treatment landscape in prostate cancer (PCa). Currently, standard of care includes either conventional and molecular imaging at time of biochemical recurrence (BCR). This study evaluated the determinants… read more here.
Keywords: evaluating determinants; prostate cancer; cancer; molecular imaging ... See more keywords